Matthew C Kapusta - Net Worth and Insider Trading

Matthew C Kapusta Net Worth

The estimated net worth of Matthew C Kapusta is at least $2 Million dollars as of 2024-03-29. Matthew C Kapusta is the CEO, Managing Director of uniQure NV and owns about 440,839 shares of uniQure NV (QURE) stock worth over $2 Million. Matthew C Kapusta is also the SVP, Business Development of AngioDynamics Inc and owns about 27,005 shares of AngioDynamics Inc (ANGO) stock worth over $158,654. Details can be seen in Matthew C Kapusta's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew C Kapusta has not made any transactions after 2024-02-26 and currently still holds the listed stock(s).

Transaction Summary of Matthew C Kapusta

To

Matthew C Kapusta Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew C Kapusta owns 3 companies in total, including uniQure NV () , AngioDynamics Inc () , and Decibel Therapeutics Inc () .

Click here to see the complete history of Matthew C Kapusta’s form 4 insider trades.

Insider Ownership Summary of Matthew C Kapusta

Ticker Comapny Transaction Date Type of Owner
uniQure NV 2024-02-26 director & CEO & Managing Director
AngioDynamics Inc 2014-04-14 SVP & Business Development
Decibel Therapeutics Inc 2023-03-19 director

Matthew C Kapusta Latest Holdings Summary

Matthew C Kapusta currently owns a total of 2 stocks. Among these stocks, Matthew C Kapusta owns 440,839 shares of uniQure NV (QURE) as of February 26, 2024, with a value of $2 Million and a weighting of 93.53%. Matthew C Kapusta also owns 27,005 shares of AngioDynamics Inc (ANGO) as of April 14, 2014, with a value of $158,654 and a weighting of 6.47%.

Latest Holdings of Matthew C Kapusta

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
QURE uniQure NV 2024-02-26 440,839 5.20 2,292,363
ANGO AngioDynamics Inc 2014-04-14 27,005 5.88 158,654

Holding Weightings of Matthew C Kapusta


Matthew C Kapusta Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew C Kapusta has made a total of 38 transactions in uniQure NV (QURE) over the past 5 years, including 0 buys and 38 sells. The most-recent trade in uniQure NV is the sale of 27,904 shares on February 26, 2024, which brought Matthew C Kapusta around $177,190.

According to the SEC Form 4 filings, Matthew C Kapusta has made a total of 0 transactions in AngioDynamics Inc (ANGO) over the past 5 years. The most-recent trade in AngioDynamics Inc is the acquisition of 1,000 shares on April 14, 2014, which cost Matthew C Kapusta around $13,900.

Insider Trading History of Matthew C Kapusta

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew C Kapusta Trading Performance

GuruFocus tracks the stock performance after each of Matthew C Kapusta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew C Kapusta is 3.35%. GuruFocus also compares Matthew C Kapusta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew C Kapusta within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Matthew C Kapusta's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Matthew C Kapusta

Average Relative Return

4.32%

Average relative return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 2.07 3.35 5.07 4.32 3.35 7.74
Relative Return to S&P 500(%) 0.51 -0.02 1.07 -11.36 -8.07 -4.27

Matthew C Kapusta Ownership Network

Ownership Network List of Matthew C Kapusta

No Data

Ownership Network Relation of Matthew C Kapusta


Matthew C Kapusta Owned Company Details

What does uniQure NV do?

Who are the key executives at uniQure NV?

Matthew C Kapusta is the director & CEO & Managing Director of uniQure NV. Other key executives at uniQure NV include Chief Financial Officer Christian Klemt , Chief Operating Officer Pierre Caloz , and Chief Medical Officer Walid Abi-saab .

uniQure NV () Insider Trades Summary

Over the past 18 months, Matthew C Kapusta made 3 insider transaction in uniQure NV () with a net sale of 37,073. Other recent insider transactions involving uniQure NV () include a net sale of 31,423 shares made by Pierre Caloz , a net sale of 21,275 shares made by Paula Soteropoulos , and a net sale of 21,087 shares made by Christian Klemt .

In summary, during the past 3 months, insiders sold 53,265 shares of uniQure NV () in total and bought 0 shares, with a net sale of 53,265 shares. During the past 18 months, 140,026 shares of uniQure NV () were sold and 0 shares were bought by its insiders, resulting in a net sale of 140,026 shares.

uniQure NV ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

uniQure NV Insider Transactions

No Available Data

Matthew C Kapusta Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew C Kapusta. You might contact Matthew C Kapusta via mailing address: 7358 Mcvay Road, Germantown Tn 38138.

Discussions on Matthew C Kapusta

No discussions yet.